Mizuho analyst Ann Hynes lowered the firm’s price target on Medpace (MEDP) to $355 from $400 and keeps an Outperform rating on the shares. The ...

Medpace Hldgs MEDP has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings ...

Medpace Hldgs (NASDAQ:MEDP) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ...